معرفی
Dr. Gary Low is an Adjunct Senior Lecturer at the Nepean Clinical School, Sydney Medical School, University of Sydney, and a biostatistician at Nepean Blue Mountain Local Health District. He holds degrees in medicine (MBBS), public health (MPH), and a PhD in biostatistics. His expertise spans health-related quantitative research methods, statistical modeling for disease outcome prediction, and clinical trial design.
Research interests include diagnostic test accuracy studies, longitudinal cohort analyses, and Bayesian statistical approaches. He actively supports clinical research through methodological guidance and statistical consultation for healthcare institutions.
Recent publications focus on maternal-neonatal health disparities, cardiotoxicity prevention in cancer patients, and dengue epidemiology. Notable work includes a 2024 cohort study on First Nations Australian maternal health outcomes and a 2024 meta-analysis on kidney adverse effects of immune checkpoint inhibitors.
Dr. Low has contributed to over 40 peer-reviewed articles, emphasizing translational research with applications in public health policy and clinical decision-making. His work bridges statistical rigor with practical healthcare challenges, particularly in underserved populations.